Ray Dalio's position in Alnylam Pharmaceuticals is currently worth $1.62 Million. That's 0.01% of their equity portfolio (437th largest holding). The first Alnylam Pharmaceuticals trade was made in Q2 2021. Since then Ray Dalio bought shares seven more times and sold shares on five occasions. The investor's estimated purchase price is $1.69 Million, resulting in a loss of 4.0%.